Healthcare Services

Gastric Cancer Market Insights Exploring Expansion Opportunities Through 2030

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Forecasted Market Size Of The Gastric Cancer Market Compare Between 2026 And 2030?

The gastric cancer market has experienced significant expansion in recent years. It is projected to grow from $3.64 billion in 2025 to $4.19 billion in 2026, at a compound annual growth rate (CAGR) of 15.2%. Historically, this market’s growth can be linked to the high prevalence of helicobacter pylori infection, smoking and dietary risk factors, the expansion of chemotherapy usage, the growth of hospital-based oncology care, and the development of surgical oncology.

The gastric cancer market is projected to experience substantial expansion in the coming years. It is anticipated to reach $7.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. This anticipated growth during the forecast period is fueled by progress in immuno-oncology, the expansion of precision diagnostics, an increase in cancer screening initiatives, the growing number of elderly individuals, and the creation of innovative targeted medications. Key trends expected over the forecast period encompass the increasing embrace of targeted and immunotherapies, a greater emphasis on early detection and screening, the broadening of personalized cancer treatment strategies, the increasing application of combination therapy protocols, and enhanced multidisciplinary cancer care frameworks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

Which Growth Drivers Are Expected To Support The Gastric Cancer Market Forward?

The rising obesity rates are anticipated to propel the growth of the gastric cancer market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat, generally defined by a body mass index (BMI) of 30 or higher, which can lead to various health complications. The increase in obesity rates stems from factors such as poor dietary habits, lack of physical activity, sedentary lifestyles, environmental influences, and genetic predispositions. Excess body fat, particularly visceral fat found around the abdomen, is linked to a heightened risk of developing gastric cancer, as obesity triggers chronic inflammation and metabolic disturbances, both of which are associated with cancer development, thus contributing to a rise in the demand for gastric cancer treatment. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that over 1 billion individuals worldwide now live with obesity, representing one in eight people. Therefore, the escalating obesity rates are driving the gastric cancer market.

How Are Different Segment Groups Identified Within The Gastric Cancer Market?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Which Trends Are Expected To Shape The Gastric Cancer Market?

Leading companies in the gastric cancer market are concentrating on developing sophisticated technological solutions, such as companion diagnostic assays, to facilitate personalized treatment. A companion diagnostic assay is a test designed to identify patients most likely to benefit from a specific therapeutic treatment based on the presence of certain biomarkers. For instance, in October 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, announced U.S. Food and Drug Administration (FDA) approval for the VENTANA CLDN18 (43-14A) RxDx Assay, which is the first immunohistochemistry (IHC) companion diagnostic for assessing CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay pinpoints patients eligible for targeted treatment with VYLOY (zolbetuximab) by measuring CLDN18 protein variants, primarily CLDN18. 2. Utilizing the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, the test advances personalized healthcare, broadening treatment options for gastric and GEJ adenocarcinoma.

Which Organizations Are Involved In The Gastric Cancer Market?

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd

Access The Complete Gastric Cancer Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

Which Region Contributes The Most To The Gastric Cancer Market?

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastric Cancer Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20797&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Market 2026, By The Business Research Company

Kernicterus Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Rare Neurological Disease Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Zollinger Ellison Syndrome Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/zollinger-ellison-syndrome-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795